The Scientist

» Alzheimer's Disease and disease/medicine

Most Recent

image: Breaching the Blood-Brain Barrier

Breaching the Blood-Brain Barrier

By | November 11, 2015

Researchers deliver cancer-fighting drugs to a patient’s brain via the bloodstream, penetrating the blood-brain barrier for the first time.

0 Comments

image: Life Scientists Honored

Life Scientists Honored

By | November 9, 2015

Breakthrough Prizes of $3 million each go to five researchers in the life sciences, recognizing their pioneering work in optogenetics, disease-associated mutation analyses, and ancient DNA sequencing.

1 Comment

Some antibodies designed to eliminate the plaques prominent in Alzheimer’s disease can aggravate neuronal hyperactivity in mice.

1 Comment

image: Week in Review: November 2–6

Week in Review: November 2–6

By | November 6, 2015

How Ebola hides from immune cells; gut microbes’ role in immunotherapy response; new mechanisms of hearing loss; butterflies use milkweed toxins to ward off predators

0 Comments

image: A Weighty Anomaly

A Weighty Anomaly

By | November 1, 2015

Why do some obese people actually experience health benefits?

3 Comments

image: Battling the Bulge

Battling the Bulge

By | November 1, 2015

Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

0 Comments

image: Contributors

Contributors

By | November 1, 2015

Meet some of the people featured in the November 2015 issue of The Scientist.

0 Comments

image: Weight's the Matter?

Weight's the Matter?

By | November 1, 2015

The causes and consequences of obesity are more complicated than we thought.  

0 Comments

image: Toward Protecting Participants’ Privacy

Toward Protecting Participants’ Privacy

By | October 29, 2015

Genomic data shared via the Beacon Project are vulnerable to privacy breaches, scientists show.

1 Comment

image: FDA OKs Herpesvirus to Treat Cancer

FDA OKs Herpesvirus to Treat Cancer

By | October 28, 2015

The US Food and Drug Administration’s approval of an engineered herpesvirus for the treatment of melanoma marks the first oncolytic virus to enter the market.

0 Comments

Popular Now

  1. An Aging-Related Effect on the Circadian Clock
  2. Marching for Science, from Berlin to Sydney
  3. Opinion: Is a Clone Really Born at Age Zero?
  4. ADHD Linked to Structural Differences in the Brain
Business Birmingham